ABBOTT LABORATORIESABTバランスシート

時価総額
$2191.6億
PER
医療機器・診断・栄養製品の最大手。FreeStyle LibreのCGM、心血管デバイスやペースメーカー、AlinityやBinaxNOW等の診断システム、Similac等の栄養製品を展開。2023年4月にCSIを8.51億ドルで買収、2023年9月にBigfoot買収。世界約160カ国で展開。
2010/122011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
現金同等物3,6486,81310,8023,4754,0635,00118,6209,4073,8443,8606,8389,7999,8826,8967,616
有価証券1,8031,2854,3724,6233971,124155203242280310450288383351
現金 + 有価証券5,4518,09715,1748,0984,4606,12518,7759,6104,0864,1407,14810,24910,1707,2797,967
売掛金7,1847,6847,6133,9863,5863,4183,2485,2495,1825,4256,4146,4876,2186,5656,925
商品及び製品3,1893,2843,7922,6932,6432,5992,4343,6013,7964,3165,0125,1576,1736,5706,194
流動資産合計22,31823,76931,32319,24715,26114,15526,77620,14714,63215,66720,44124,23925,22422,67023,656
有形固定資産7,9717,8748,0635,9055,9355,7305,7057,6077,5638,0389,0298,9599,16210,15410,658
投資有価証券3023782741192294,0412,947883897883821816766799886
固定資産合計37,14536,50835,91223,70626,01427,09225,89056,10352,54152,22052,10750,95749,21450,54457,758
総資産59,46260,27767,23542,95341,27541,24752,66676,25067,17367,88772,54875,19674,43873,21481,414
一年内返済予定の長期借入金2,0451,0273099553350871,27777542,2511,0801,500
流動負債合計17,26215,48013,2809,50710,5329,1866,6608,9129,01210,86311,90713,10515,48913,84114,157
長期借入金12,52412,04018,0853,3883,4085,87120,68127,21019,35916,66118,52717,29614,52213,59912,625
資本金及び資本剰余金8,745--12,04812,38312,73413,02723,20623,51223,85324,14524,47024,70924,86925,153
利益剰余金18,92720,90724,15121,97922,87425,75725,56523,97824,56025,84727,62731,52835,25737,55447,261
株主資本22,47624,52626,81325,26721,63921,32620,71731,09830,72231,30133,00336,02436,90538,82747,901
有利子負債合計14,56813,06718,3943,3973,4485,87420,68427,71819,36617,93818,53418,05016,77314,67914,125
純有利子負債9,1174,9693,220-4,701-1,012-2511,90918,10815,28013,79811,3867,8016,6037,4006,158
DEレシオ(%)64.853.368.613.415.927.599.889.16357.356.250.145.437.829.5